BAY-3389934

N/A

Report date: 2026/03/28 20:00:32

Base Information

Drug NameBAY-3389934
Drug Alias NameBAY 3389934BAY3389934
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor IIa inhibitorsFactor Xa inhibitors
TargetsProthrombinCoagulation factor X
Therapy Area/IndicationsDisseminated Intravascular CoagulationBlood Coagulation DisordersCardiovascular Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumNetherlandsGermany +[5] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsDisseminated Intravascular CoagulationBlood Coagulation DisordersCardiovascular Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A